Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOAC versus VKA anticoagulation for Balloon Pulmonary Angioplasty in CTEPH/CTED
NL-OMON60100Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, sponsored by St. Antonius Ziekenhuis. Started Nov 2024; status: active, not recruiting.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on NL-OMON60100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60100.